Neurocrine Biosciences
NBIX
$138.97
Share price
-0.80%
Change (1 day)
34.19%
Change (1 year)
Categories
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.
Number of shares outstanding for Neurocrine Biosciences (NBIX)
Number of shares outstanding as of April 2024 : 97,900,000
According to Neurocrine Biosciences 's latest financial reports and stock price the company's current number of shares outstanding is 97,900,000. At the end of 2023 the company had 97,900,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Neurocrine Biosciences from 2001 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 97.9 M | 1.66% |
| 2022 | 96.3 M | 1.48% |
| 2021 | 94.9 M | 1.5% |
| 2020 | 93.5 M | 1.41% |
| 2019 | 92.2 M | 1.61% |
| 2018 | 90.74 M | 2.34% |
| 2017 | 88.66 M | 2.06% |
| 2016 | 86.87 M | 0.8% |
| 2015 | 86.18 M | 13.19% |
| 2014 | 76.13 M | 13.06% |
| 2013 | 67.34 M | 1.42% |
| 2012 | 66.4 M | 20.2% |
| 2011 | 55.24 M | 0.74% |
| 2010 | 54.84 M | 40.28% |
| 2009 | 39.09 M | 1.69% |
| 2008 | 38.44 M | 1.2% |
| 2007 | 37.99 M | 0.32% |
| 2006 | 37.86 M | 3.16% |
| 2005 | 36.7 M | 0.77% |
| 2004 | 36.42 M | 13.65% |
| 2003 | 32.05 M | 5.02% |
| 2002 | 30.52 M | 18.23% |
| 2001 | 25.81 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 5,647,000,000 | 5,668.13% | 🇺🇸 USA |
 AbbVie ABBV | 1,765,940,733 | 1,703.82% | 🇺🇸 USA |
 Eli Lilly LLY | 949,379,000 | 869.74% | 🇺🇸 USA |
 Repligen
RGEN | 55,815,666 | -42.99% | 🇺🇸 USA |
 Athersys ATHX | 24,492,000 | -74.98% | 🇺🇸 USA |
 ANI Pharmaceuticals ANIP | 18,883,000 | -80.71% | 🇺🇸 USA |
 Palatin Technologies PTN | 14,097,757 | -85.60% | 🇺🇸 USA |
 Royalty Pharma RPRX | 448,439,000 | 358.06% | 🇬🇧 UK |